1. Aktas EG, Kaplan M, Ozveren MF. Basilar artery aneurysm associated with Behçet's Disease: a case report. Turk Neurosurg. 2008; 1. 18(1):35–38. PMID:
18382975.
2. Asano T, Ikegaki I, Suzuki Y, Satoh S, Shibuya M. Endothelin and the production of cerebral vasospasm in dogs. Biochem Biophys Res Commun. 1989; 3. 159(3):1345–1351. PMID:
2649099.
Article
3. Buge A, Vincent D, Rancurel G, Dechy H, Dorra M, Betourne C. Behçet's diseases with multiple intracranial arterial aneurysms. Rev Neurol (Paris). 1987; 12. 143(12):832–835. PMID:
3326112.
4. Cevik C, Otahbachi M, Nugent K, Jenkins LA. Coronary artery aneurysms in Behçet's disease. Cardiovasc Revasc Med. 2009; Apr-Jun. 10(2):128–129. PMID:
19327677.
Article
5. Choe JY, Park SH, Kim SK. Serum angiopoietin-1 level is increased in patients with Behçet's disease. Joint Bone Spine. 2010; 7. 77(4):340–344. PMID:
20471887.
Article
6. el Abbadi N, el Mostarchid B, Ababou A, Mosadik A, Semlali A, Bellakhdar F. Behcet's disease with multiple intracranial arterial aneurysms. Report of a case. J Mal Vasc. 1999; 6. 24(3):225–228. PMID:
10467534.
7. Juvela S. Plasma endothelin and big endothelin concentrations and serum endothelin-converting enzyme activity following aneurysmal subarachnoid hemorrhage. J Neurosurg. 2002; 12. 97(6):1287–1293. PMID:
12507125.
Article
8. Kaku Y, Hamada JI, Kuroda JI, Kai Y, Morioka M, Kuratsu JI. Multiple peripheral middle cerebral artery aneurysms associated with behcet's disease. Acta Neurochir (Wien). 2007; 8. 149(8):823–827. discussion 827PMID:
17585365.
Article
9. Kato Y, Terashima M, Ohigashi H, Tezuka D, Ashikaga T, Hirao K, et al. Vessel wall inflammation of takayasu arteritis detected by contrast-enhanced magnetic resonance imaging: Association with disease distribution and activity. PLoS One. 2015; 12. 10(12):e0145855. PMID:
26720837.
Article
10. Kiraz S, Ertenli I, Calguneri M, Ozturk MA, Haznedaroglu IC, Altun B, et al. Interactions of nitric oxide and superoxide dismutase in Behçet's disease. Clin Exp Rheumatol. 2001; Sep-Oct. 19(5 Suppl 24):S25–S29. PMID:
11760394.
11. Kobayashi H, Ide H, Ishii H, Kabuto M, Handa Y, Kubota T. Endothelin-1 levels in plasma and cerebrospinal fluid-following subarachnoid haemorrhage. J Clin Neurosci. 1995; 7. 2(3):252–256. PMID:
18638823.
Article
12. Kolias AG, Sen J, Belli A. Pathogenesis of cerebral vasospasm following aneurysmal subarachnoid hemorrhage: Putative mechanisms and novel approaches. J Neurosci Res. 2009; 1. 87(1):1–11. PMID:
18709660.
Article
13. Macdonald RL. Endothelin antagonists in subarachnoid hemorrhage: What next? Crit Care. 2012; 11. 16(6):171. PMID:
23146320.
Article
14. Murat A, Cemile K, Sema U, Yüksel T, Ramazan Y, Ferah A, et al. Serum nitric oxide, asymmetric dimethylarginine, and plasma homocysteine levels in active Behçets disease. Turk J Med Sci. 012; 9. 42(Suppl 1):1194–1199.
15. Ng WH, Moochhala S, Yeo TT, Ong PL, Ng PY. Nitric oxide and subarachnoid hemorrhage: Elevated level in cerebrospinal fluid and their implications. Neurosurgery. 2001; 9. 49(3):622–626. discussion 626-7PMID:
11523672.
16. Nishizawa S, Chen D, Yokoyama T, Yokota N, Otha S. Endothelin-1 initiates the development of vasospasm after subarachnoid haemorrhage through protein kinase c activation, but does not contribute to prolonged vasospasm. Acta Neurochir (Wien). 2000; 12. 142(12):1409–1415. PMID:
11214636.
Article
17. Nishizawa S, Laher I. Signaling mechanisms in cerebral vasospasm. Trends Cardiovasc Med. 2005; 1. 15(1):24–34. PMID:
15795160.
Article
18. Thampatty BP, Sherwood PR, Gallek MJ, Crago EA, Ren D, Hricik AJ, et al. Role of endothelin-1 in human aneurysmal subarachnoid hemorrhage: Associations with vasospasm and delayed cerebral ischemia. Neurocrit Care. 2011; 8. 15(1):19–27. PMID:
21286855.
Article
19. Tsuji S, Suzuki Y, Tomii M, Matsuoka Y, Kishimoto H, Irimajiri S. Behçet's disease associated with multiple cerebral aneurysms and downhill esophageal varices caused by superior vena cava obstruction: a case report. Ryumachi. 1990; 10. 30(5):375–379. discussion 379-81PMID:
2084860.
20. Ural AU. Increased plasma endothelin-1 levels in active behcet's disease. Clin Rheumatol. 1997; 11. 16(6):640. PMID:
9456026.
21. Uslu T, Erem C, Tosun M, Deger O. Plasma endothelin-1 levels in behcet's disease. Clin Rheumatol. 1997; 1. 16(1):59–61. PMID:
9132327.
22. Zimmermann M, Seifert V. Endothelin receptor antagonists and cerebral vasospasm. Clin Auton Res. 2004; 6. 14(3):143–145. PMID:
15241641.
Article